Search research articles
Contact Us
Filters
Showing results (1-10 of 57) with videos related to
Page
of 6
Sort By:
Breast Disease
|
February 3, 2005
Effects of geldanamycin and other naturally occurring small molecule antagonists of heat shock protein 90 on HER2 protein expression
L Neckers
Handbook of Experimental Pharmacology
|
April 14, 2006
Chaperoning oncogenes: Hsp90 as a target of geldanamycin
L Neckers
The American Journal of Physiology
|
July 1, 1993
Antisense technology: biological utility and practical considerations
L Neckers, L Whitesell
Transplantation
|
July 1, 1984
Mononuclear cell-surface antigens during storage of banked blood
W H Dzik, L Neckers
Brain Research
|
July 25, 1975
Regulation of 5-hydroxytryptamine metabolism in mouse brain by adrenal glucocorticoids
L Neckers, P Y Sze
Molecular Pharmacology
|
October 1, 1995
Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers
C Chavany, Y Connell, L Neckers
Investigational New Drugs
|
April 12, 2000
Geldanamycin as a potential anti-cancer agent: its molecular target and biochemical activity
L Neckers, T W Schulte, E Mimnaugh
Oncogene
|
September 7, 1995
Geldanamycin selectively destabilizes and conformationally alters mutated p53
M V Blagosklonny, J Toretsky, L Neckers
British Journal of Cancer
|
January 11, 2007
HIF and fumarate hydratase in renal cancer
S Sudarshan, W M Linehan, L Neckers
The Journal of Biological Chemistry
|
September 13, 1996
Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin
E G Mimnaugh, C Chavany, L Neckers
Page
of 6
Search research articles
Search
Showing results (1-10 of 57) with videos related to
Sort By:
Page
of 6
Breast Disease
|
February 3, 2005
Effects of geldanamycin and other naturally occurring small molecule antagonists of heat shock protein 90 on HER2 protein expression
L Neckers
Handbook of Experimental Pharmacology
|
April 14, 2006
Chaperoning oncogenes: Hsp90 as a target of geldanamycin
L Neckers
The American Journal of Physiology
|
July 1, 1993
Antisense technology: biological utility and practical considerations
L Neckers, L Whitesell
Transplantation
|
July 1, 1984
Mononuclear cell-surface antigens during storage of banked blood
W H Dzik, L Neckers
Brain Research
|
July 25, 1975
Regulation of 5-hydroxytryptamine metabolism in mouse brain by adrenal glucocorticoids
L Neckers, P Y Sze
Molecular Pharmacology
|
October 1, 1995
Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers
C Chavany, Y Connell, L Neckers
Investigational New Drugs
|
April 12, 2000
Geldanamycin as a potential anti-cancer agent: its molecular target and biochemical activity
L Neckers, T W Schulte, E Mimnaugh
Oncogene
|
September 7, 1995
Geldanamycin selectively destabilizes and conformationally alters mutated p53
M V Blagosklonny, J Toretsky, L Neckers
British Journal of Cancer
|
January 11, 2007
HIF and fumarate hydratase in renal cancer
S Sudarshan, W M Linehan, L Neckers
The Journal of Biological Chemistry
|
September 13, 1996
Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin
E G Mimnaugh, C Chavany, L Neckers
Page
of 6